A.R.T. Advisors’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-302
Closed -$16K 1839
2019
Q2
$16K Sell
302
-321
-52% -$55.7K ﹤0.01% 1302
2019
Q1
$135K Buy
623
+101
+19% +$40.7K 0.01% 1140
2018
Q4
$181K Buy
+522
New +$406K 0.01% 1086
2018
Q2
Sell
-58
Closed -$68K 1874
2018
Q1
$68K Buy
+58
New +$64.1K ﹤0.01% 1384
2016
Q1
Sell
-441
Closed -$253K 1740
2015
Q4
$253K Buy
441
+182
+70% +$128K 0.01% 1117
2015
Q3
$230K Sell
259
-126
-33% -$115K 0.01% 1133
2015
Q2
$396K Sell
385
-112
-23% -$131K 0.01% 1084
2015
Q1
$707K Buy
+497
New +$630K 0.02% 788

Other funds holding HSTO

A.R.T. Advisors's HSTO Position: Q3 2019 in Review

A.R.T. Advisors sold out of Histogen Inc. Common Stock (HSTO) in Q3 2019, closing a stake of 302 shares — an estimated $16K sold.

A.R.T. Advisors first reported a position in HSTO in Q1 2015 and held it in 8 quarters. The position peaked at $707K in Q1 2015. 29 funds tracked by Wall St. Rank hold HSTO as of Q3 2019.

  • A.R.T. Advisors reported no remaining Histogen Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 302 Histogen Inc. Common Stock shares in Q3 2019, an estimated $16K.
  • A.R.T. Advisors first reported a position in Histogen Inc. Common Stock in Q1 2015 and held it in 8 quarters.
  • A.R.T. Advisors's Histogen Inc. Common Stock position peaked at $707K in Q1 2015.
  • 29 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.